IO Biotech Statistics
Total Valuation
IO Biotech has a market cap or net worth of $51.39 million. The enterprise value is -$24.10 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 92.75% in one year.
Current Share Class | 65.88M |
Shares Outstanding | 65.88M |
Shares Change (YoY) | +92.75% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.23% |
Owned by Institutions (%) | 18.53% |
Float | 27.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.75 |
P/TBV Ratio | 0.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.03.
Current Ratio | 5.37 |
Quick Ratio | 5.05 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.50% and return on invested capital (ROIC) is -51.33%.
Return on Equity (ROE) | -78.50% |
Return on Assets (ROA) | -45.91% |
Return on Capital (ROIC) | -51.33% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.33M |
Employee Count | 68 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IO Biotech has paid $1.35 million in taxes.
Income Tax | 1.35M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.47% in the last 52 weeks. The beta is 0.42, so IO Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -17.47% |
50-Day Moving Average | 1.09 |
200-Day Moving Average | 1.35 |
Relative Strength Index (RSI) | 32.75 |
Average Volume (20 Days) | 324,571 |
Short Selling Information
The latest short interest is 200,923, so 0.30% of the outstanding shares have been sold short.
Short Interest | 200,923 |
Short Previous Month | 277,050 |
Short % of Shares Out | 0.30% |
Short % of Float | 0.72% |
Short Ratio (days to cover) | 1.89 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -96.42M |
Pretax Income | -87.64M |
Net Income | -90.34M |
EBITDA | -96.17M |
EBIT | -96.42M |
Earnings Per Share (EPS) | -$1.37 |
Full Income Statement Balance Sheet
The company has $80.19 million in cash and $2.02 million in debt, giving a net cash position of $78.17 million or $1.19 per share.
Cash & Cash Equivalents | 80.19M |
Total Debt | 2.02M |
Net Cash | 78.17M |
Net Cash Per Share | $1.19 |
Equity (Book Value) | 72.57M |
Book Value Per Share | 1.10 |
Working Capital | 70.19M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -85.52M |
Capital Expenditures | -145,000 |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IO Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -92.75% |
Shareholder Yield | -92.75% |
Earnings Yield | -167.10% |
FCF Yield | n/a |
Analyst Forecast
The average price target for IO Biotech is $9.33, which is 1,096.15% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.33 |
Price Target Difference | 1,096.15% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -28.20% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |